SUN PHARMACEUTICAL INDUSTRIES LTD. - Update On Halol Facility

Download	< Back
13 Aug 2022
This is with respect to our communication dated May 10, 2022 regarding the US FDA inspection at the Company's Halol (Gujarat) facility from April 26 to May 9, 2022 and issuance of Form-483 by US FDA with 10 observations. We now wish to inform you that the Company has received a communication from the US FDA indicating the inspection classification as 'Official Action Indicated' (OAI).
View all announcements for SUN PHARMACEUTICAL INDUSTRIES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us